- Posters
- Publications
- Therapeutic Monoclonal Antibodies
- Monoclonal
- Multi-meric Membrane
- Multi-pass transmembrane
- Transgenic Animals
- Antibody Discovery
- Human Therapeutic Antibodies
- Hybridoma
- SARS-CoV-2
- APOBEC3G
- ARMER
- ATX-GX
- Alloy Therapeutics
- Anti-idiotype
- Antibody Generation
- BRCA2
- CEM15
- Cadherin-11
- Carcinogenesis
- Conditioned Media
- Critical Reagents
- Cystine Knot Peptides
- D Protein
- DLL4
- ELISAs
- Fully Human
- HIV-1
- HSA
- IL-1 alpha
- Immune B-cells
- Immunization
- Knottins
- L-amino acids
- L-selectin
- LAM
- LBAs
- LOXL2
- Lymphangioleiomyomatosis
- McAbs
- OmniAb
- OmniRat
- PNAd
- Pharmacokinetic (PK)
- Prolactin
- Secretion Capture Report Web
- Stereochemistry
- Therapeutic Targets
- Tissue Culture
- Transgenic H2L2 Mice
- VEGF-A
- VEGF-C
- VEGF-D
- p53
1 min read
Generation Using a Molecular Modeling Platform to Guide Therapeutic Antibody Discovery
"Using a Molecular Modeling Platform to Guide Therapeutic Antibody Discovery” details the integration of advanced 3-D modeling tools for the analysis...
1 min read
Generation of Agonist and Antagonist Human Monoclonal Antibodies Against an Immune Checkpoint Target from the H2L2 Mouse
Immunization of transgenic animals producing human antibodies is by far the most successful approach to obtaining “fully human” therapeutic...
1 min read
Optimization of Therapeutic Discovery Strategies for Human Antibody Transgenic Animal Platforms
Immunization of transgenic animals producing human antibodies has been the most successful approach to obtaining fully human therapeutic antibodies....